Nonadherence to statins: individualized intervention strategies outside the pill box

被引:50
作者
Lansberg, Peter [1 ]
Lee, Andre [2 ]
Lee, Zhen-Vin [3 ]
Subramaniam, Kannan [4 ]
Setia, Sajita [5 ]
机构
[1] Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands
[2] Natl Univ Singapore, Dept Pharm, Singapore, Singapore
[3] Univ Malaya, Med Ctr, Dept Med, Cardiol Unit, Kuala Lumpur, Malaysia
[4] Global Med Affairs, Pfizer Australia, West Ryde, NSW, Australia
[5] Pfizer Pte Ltd, Med Affairs, 80 Pasir Panjang Rd,16-81-82, Singapore 117372, Singapore
关键词
cardiovascular disease; nonadherence; nocebo; myopathy; statins;
D O I
10.2147/VHRM.S158641
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Poor adherence to statin therapy is linked to significantly increased risk of cardiovascular events and death. Unfortunately, adherence to statins is far from optimal. This is an alarming concern for patients prescribed potentially life-saving cholesterol-lowering medication, especially for those at high risk of cardiovascular events. Research on statin adherence has only recently garnered broader attention; hence, major reasons unique to adherence to statin therapy need to be identified as well as suggestions for countermeasures. An integrated approach to minimizing barriers and enhancing facilitation at the levels of the patient, provider, and health system can help address adherence issues. Health care professionals including physicians, pharmacists, and nurses have an obligation to improve patient adherence, as routine care. In order to achieve sustained results, a multifaceted approach is indispensable.
引用
收藏
页码:91 / 102
页数:12
相关论文
共 92 条
[1]  
American College of Cardiology, 2017, ACC STAT INT APP
[2]   Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].
Baigent, C ;
Keech, A ;
Kearney, PM ;
Blackwell, L ;
Buck, G ;
Pollicino, C ;
Kirby, A ;
Sourjina, T ;
Peto, R ;
Collins, R ;
Simes, J .
LANCET, 2005, 366 (9493) :1267-1278
[3]   Communicating statin evidence to support shared decision-making [J].
Barrett, Bruce ;
Ricco, Jason ;
Wallace, Margaret ;
Kiefer, David ;
Rakel, Dave .
BMC FAMILY PRACTICE, 2016, 17
[4]   Global public health: a scorecard [J].
Beaglehole, Robert ;
Bonita, Ruth .
LANCET, 2008, 372 (9654) :1988-1996
[5]   Long-term persistence in use of statin therapy in elderly patients [J].
Benner, JS ;
Glynn, RJ ;
Mogun, H ;
Neumann, PJ ;
Weinstein, MC ;
Avorn, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (04) :455-461
[6]   Prospective Analysis of LDL-C Goal Achievement and Self-Reported Medication Adherence Among Statin Users in Primary Care [J].
Bermingham, Margaret ;
Hayden, John ;
Dawkins, Ian ;
Miwa, Saki ;
Gibson, Denise ;
McDonald, Kenneth ;
Ledwidge, Mark .
CLINICAL THERAPEUTICS, 2011, 33 (09) :1180-1189
[7]   The diabetogenic action of statins - mechanisms and clinical implications [J].
Betteridge, D. John ;
Carmena, Rafael .
NATURE REVIEWS ENDOCRINOLOGY, 2016, 12 (02) :99-110
[8]   Rosuvastatin pharmacokinetics and pharmacogenetics in Caucasian and Asian subjects residing in the United States [J].
Birmingham, Bruce K. ;
Bujac, Sarah R. ;
Elsby, Robert ;
Azumaya, Connie T. ;
Zalikowski, Julie ;
Chen, Yusong ;
Kim, Kenneth ;
Ambrose, Helen J. .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (03) :329-340
[9]   Effect of drug reminder packaging on medication adherence: A systematic review revealing research gaps [J].
Boeni F. ;
Spinatsch E. ;
Suter K. ;
Hersberger K.E. ;
Arnet I. .
Systematic Reviews, 3 (1)
[10]   Patient-focused intervention to improve long-term adherence to evidence-based medications: A randomized trial [J].
Calvert, Sara Bristol ;
Kramer, Judith M. ;
Anstrom, Kevin J. ;
Kaltenbach, Lisa A. ;
Stafford, Judith A. ;
LaPointe, Nancy M. Allen .
AMERICAN HEART JOURNAL, 2012, 163 (04) :657-+